Press Releases
Universal Electronics Inc. (UEI) (NASDAQ: UEIC), the global leader in wireless universal control solutions for home entertainment and smart home devices, will host a conference call at 4:30 p.m. ET on Thursday, March 12, 2026, to discuss its fourth quarter 2025 financial results. Management will provide a financial and business update as well as answer questions.
By Universal Electronics Inc. · Via Business Wire · March 4, 2026
WSFS Financial Corporation (Nasdaq: WSFS), the parent company of WSFS Bank, will participate in the 2026 RBC Capital Markets Global Financial Institutions Conference on March 11, 2026, in New York City. David Burg, Executive Vice President, Chief Financial Officer, Arthur J. Bacci, Executive Vice President, Chief Operating Officer, and Andrew Basile, Vice President, Head of Investor Relations will host discussions with investors.
By WSFS Financial Corporation · Via Business Wire · March 4, 2026
CHAPEL HILL, N.C., March 04, 2026 (GLOBE NEWSWIRE) -- James River Group Holdings, Inc. ("James River" or the "Company") (NASDAQ: JRVR) today announced that Kelly Hadiaris has re-joined the Company as Senior Vice President, Underwriting – Excess Casualty, to lead the Excess Casualty division within its Excess and Surplus (“E&S”) segment. Ms. Hadiaris will report to Todd Sutherland, President of the E&S segment.
By James River Group Holdings, Inc. · Via GlobeNewswire · March 4, 2026
Refinancing Strengthens Capital Structure by Extending Debt Maturity and Providing Access to Additional Undrawn Capital
By Pulmonx Corporation · Via GlobeNewswire · March 4, 2026
Five ways quantum technology shapes daily life
When most Australians hear the word “quantum”, they think of something futuristic. A lab experiment. A distant breakthrough. Perhaps something to do with quantum computers...?
Via AB Newswire · March 4, 2026
Paragon Announces Final Resolution of Legacy Litigation Liabilities Created by Prior Board
Via ACCESS Newswire · March 4, 2026
MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today reported its financial results for the fourth quarter and full year ended December 31, 2025 and raised guidance for full year 2026.
By BillionToOne, Inc. · Via GlobeNewswire · March 4, 2026
NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee.
By Teladoc Health, Inc. · Via GlobeNewswire · March 4, 2026
SAXONBURG, Pa., March 04, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced the launch of its CHR1074 224Gbps quad-channel transimpedance amplifier (TIA) designed to power next-generation 800G and 1.6T optical transceivers. Engineered for high-performance AI and cloud infrastructure, the CHR1074 combines ultra-fast link recovery with intelligent power management to improve efficiency and reduce latency in increasingly dynamic data center environments.
By Coherent Corp. · Via GlobeNewswire · March 4, 2026
Fourth Quarter Results
By NCS Multistage Holdings, Inc. · Via GlobeNewswire · March 4, 2026
Fourth Quarter Revenue Increased 20% to a Record $23.4 Million
By Red Violet, Inc. · Via GlobeNewswire · March 4, 2026
IRVINE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, and Steven Perrin, Ph.D., President and Chief Scientific Officer, will participate in a fireside chat at the upcoming Leerink Partners 2026 Global Healthcare Conference on Wednesday, March 11, 2026, at 1:40 p.m. ET (10:40 a.m. PT).
By Eledon Pharmaceuticals, Inc. · Via GlobeNewswire · March 4, 2026
SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on March 2, 2026, the Company granted restricted stock units (RSUs) representing 50,700 shares of its common stock to three newly-hired non-executive employees. The grants were approved by the Compensation Committee of the Company’s Board of Directors and granted under the Company’s Amended and Restated Inducement Equity Plan as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employees being continuously employed by the Company through each vesting date.
By Fate Therapeutics, Inc. · Via GlobeNewswire · March 4, 2026
Free global platform provides healthcare professionals with 1,000+ premium courses and clinical images, including specialized training on AI-enhanced ultrasound diagnostics
Via AB Newswire · March 4, 2026
Industry Analyst: MWC 2026 ushers in new AI – 5G – 6G Era to wireless world
MWC Barcelona 2026 offers a clear preview of what is coming next as artificial intelligence and 5G converge to reshape the wireless industry. Each year, global trade shows like Mobile World Congress in Barcelona usher in new thinking, fresh ideas, and breakthrough technologies for the wireless industry. In 2026, AI and 5G stand side by side, with powerful demonstrations of how they will transform both the industry and our everyday lives.
Via AB Newswire · March 4, 2026
Smith Micro Software, Inc. (Nasdaq: SMSI) today announced that it has named current Chief Operating Officer and Chief Financial Officer Tim Huffmyer to serve as Smith Micro’s next President and Chief Executive Officer. Huffmyer will assume the role from Bill Smith, who has been appointed to the role of Executive Chairman. The changes will take effect on March 31, 2026 and follow leadership succession planning led by Smith and the Company’s Board of Directors.
By Smith Micro Software, Inc. · Via Business Wire · March 4, 2026
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies to treat severe neuromuscular and neurological diseases, today announced regulatory updates related to the FREEDOM2 trial.
By PepGen Inc. · Via Business Wire · March 4, 2026
Niagen Bioscience, Inc. (NASDAQ:NAGE) today announced its fourth quarter and fiscal year 2025 financial results.
By Niagen Bioscience, Inc · Via Business Wire · March 4, 2026
Cardlytics, Inc. (NASDAQ: CDLX) today announced financial results for the fourth quarter and full year ended December 31, 2025.
By Cardlytics, Inc. · Via Business Wire · March 4, 2026
Smith Micro Software, Inc. (the “Company” or “Smith Micro”) (NASDAQ: SMSI) today announced that it has entered into a securities purchase agreement for the sale of securities to accredited investors pursuant to an unregistered offering, the gross proceeds of which are expected to be approximately $4.9 million, which includes committed investments of approximately $4.6 million from a trust for which Bill Smith, the Company’s chief executive officer and founder, serves as co-trustee, and approximately $90 thousand from Tim Huffmyer, the Company’s chief operating officer and chief financial officer.
By Smith Micro Software, Inc. · Via Business Wire · March 4, 2026
Boynton Beach, FL - As homeowners across South Florida invest in home improvements that enhance both comfort and property value, experts at Sunline Kitchen Remodeling are encouraging residents to plan a professional Kitchen Remodel to modernize outdated kitchens and improve daily functionality. According to housing industry reports, kitchen renovations remain one of the most valuable home upgrades, often delivering some of the highest returns on investment among residential improvement projects.
Via AB Newswire · March 4, 2026
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced that Alexion Pharmaceuticals, Inc. (the “Licensee”) informed Xencor, Inc. (the “Company”) that it has taken the position that the Licensee does not owe any additional royalties for sales of Ultomiris® (ravulizumab-cwvz) in the United States and that the Licensee does not intend to make any future payments for sales in the United States. The Licensee informed the Company that it intends to continue making royalty payments for sales of Ultomiris outside the United States.
By Xencor, Inc. · Via Business Wire · March 4, 2026
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today reported financial results for the three months and full year ended December 31, 2025, and highlighted recent progress.
By Verastem Oncology · Via Business Wire · March 4, 2026
Magnachip Semiconductor Corporation (NYSE: MX) (“Magnachip” or the “Company”) today announced financial results for the fourth quarter and full year 2025.
By Magnachip Semiconductor Corporation · Via Business Wire · March 4, 2026
Everspin Technologies, Inc. (NASDAQ: MRAM), the world’s leading developer and manufacturer of magnetoresistive random access memory (MRAM) persistent memory solutions, today announced preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025.
By Everspin Technologies, Inc. · Via Business Wire · March 4, 2026
Smith Micro Software, Inc. (Nasdaq: SMSI) (“Smith Micro” or the “Company”) today reported financial results for its fourth quarter and fiscal year ended December 31, 2025.
By Smith Micro Software, Inc. · Via Business Wire · March 4, 2026
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on developing FB102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications, today announced the issuance of equity inducement awards as required by the Nasdaq Stock Market Rules.
By Forte Biosciences, Inc. · Via Business Wire · March 4, 2026
Okta, Inc. (Nasdaq: OKTA), the leading independent identity partner, today announced financial results for its fourth quarter and fiscal year ended January 31, 2026.
By Okta, Inc. · Via Business Wire · March 4, 2026
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, will hold a conference call on Thursday, March 12, 2026 at 4:30 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2025, and will be providing updates on its key strategic growth initiatives, specifically the limited commercial launch and significant developments on the 12-lead ECG extended wear patch. A press release detailing these results will be issued prior to the call.
By HeartBeam, Inc. · Via Business Wire · March 4, 2026
Mechelen, Belgium; March 4, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America.
By Galapagos NV · Via GlobeNewswire · March 4, 2026
EMERYVILLE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Grocery Outlet Holding Corp. (NASDAQ: GO) ("Grocery Outlet," the "Company," "we" or "our") today announced financial results for the fourth quarter and full fiscal year ended January 3, 2026, both of which contained one additional week ("53rd week") versus the comparable prior periods. Additionally, the Company today announced a business optimization plan (the “Optimization Plan”) to improve operational execution, strengthen long-term profitability and increase cash flow generation.
By Grocery Outlet, Inc. · Via GlobeNewswire · March 4, 2026
BOSTON, March 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that on March 2, 2026, the Compensation Committee of Praxis’ Board of Directors granted restricted stock unit awards covering an aggregate of 2,931 shares of its common stock to fourteen new non-executive employees under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the 2024 Inducement Plan). The restricted stock unit awards were granted as inducements material to the employees’ entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4).
By Praxis Precision Medicines, Inc. · Via GlobeNewswire · March 4, 2026
NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on March 1, 2026, the Company granted inducement awards to purchase up to 81,600 shares of common stock to three new employees under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and 1/48th of the underlying shares vesting monthly thereafter over 36 months, subject to the employee's continued service relationship with Syndax through the applicable vesting dates.
By Syndax Pharmaceuticals, Inc. · Via GlobeNewswire · March 4, 2026
WARREN, N.J., March 04, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a progress update on the Company's key 2026 objectives.
By Aquestive Therapeutics, Inc. · Via GlobeNewswire · March 4, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 4, 2026
REMSleep Holdings Announces Passing of Founder Thomas Wood and Appointment of Jeffrey Marshall as Chief Executive Officer
Board of Directors Reconstituted With Anita Wood as Chairman; Company Positioned for Continued Growth and Commercialization
Via TheNewswire.com · March 4, 2026
Smart calendar with no subscription fees sync with Google Calendar to ease the mental load on parents, and are now $35 off for the Spring Sale.
Via AB Newswire · March 4, 2026
NioCorp Management and Special Guest to Provide Update on the Launch of Construction of Mine Portal at the Elk Creek Critical Minerals Project in Nebraska
Via ACCESS Newswire · March 4, 2026
Discover the New Spring Collection from Catch Phrase Poet Clothing
Via TheNewswire.com · March 4, 2026
BBB National Programs’ Digital Advertising Accountability Program (DAAP) worked with Audiomob to update its privacy policy and in-app notices to bring its platform and third-party interest-based advertising (IBA) into compliance with the Digital Advertising Alliance’s (DAA) Self-Regulatory Principles.
By BBB NATIONAL PROGRAMS · Via GlobeNewswire · March 4, 2026
Pivot Bio, one of the world’s leading, innovative agtech companies, today announced it has moved its corporate headquarters to Minneapolis, Minn., relocating from its prior headquarters in Berkeley, Calif. This move further strengthens the company’s presence in the U.S. agricultural heartland.
By Pivot Bio · Via Business Wire · March 4, 2026
BROOKINGS, S.D., March 04, 2026 (GLOBE NEWSWIRE) -- Daktronics, Inc. (NASDAQ-DAKT), the leading U.S.-based designer and manufacturer of best-in-class dynamic video communication displays and control systems for customers worldwide, today announced it will host its 2026 Investor Day on Thursday, April 9, at the home of the NASDAQ MarketSite in Times Square.
By Daktronics, Inc. · Via GlobeNewswire · March 4, 2026
COLORADO - Sean Oblizalo, the Colorado-based elopement photographer and planner behind Vows and Peaks, offers a tiered suite of Colorado Elopement Packages giving couples a clear, stress-free path to getting married in the mountains on their own terms.
Via AB Newswire · March 4, 2026
Via PRLog · March 4, 2026
A sweeping, masterfully crafted work of historical fiction, Ghosts of the Revolutionary War: The Journal of a 21st Century Man Who Travels Back in Time to 1780 stands as a bold and intellectually rich contribution to Revolutionary War literature. This extraordinary novel merges elite scholarship, military expertise, and imaginative brilliance into a truly unforgettable reading experience.
Via Get News · March 4, 2026
The new report details how life sciences organizations are responding to regulatory change, resource constraints, and fragmented systems.
Via ACCESS Newswire · March 4, 2026
Bobbie, the mom-founded pediatric nutrition company, today announced that its complete line of organic and grass-fed infant formulas has been named "Top Choices" by Consumer Reports, the leading independent, nonprofit consumer advocacy organization. In two consecutive rounds of independent formula safety testing — conducted in March 2025 and March 2026 — Consumer Reports found non-detectable to low levels of heavy metals and toxins across all four of Bobbie's infant formulas, making Bobbie one of the only formula brands to achieve top-choice status across its entire product line in both rounds of testing.
By Bobbie · Via Business Wire · March 4, 2026
Botrich Inc. proudly announced its support for the official launch of the 2026 Canada Youth Business Proposal Competition, hosted by the Canada Youth Funding Association (CYFA). The February 21 launch event marks the beginning of a nationwide initiative designed to inspire creativity, entrepreneurial thinking, and structured innovation among young Canadians.
Via Get News · March 4, 2026
AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a+” (Excellent) of Equitable Financial Life Insurance Company of America (EFLICOA) (Phoenix, AZ) and Equitable Financial Life Insurance Company (EFLIC) (New York, NY). EFLICOA and EFLIC collectively are referred to as Equitable Life Group. Concurrently, AM Best has affirmed the Long-Term ICR of “bbb+” (Good) and the Long-Term Issue Credit Ratings (Long-Term IR) of Equitable Holdings, Inc. (Delaware). The outlook of these Credit Ratings (ratings) is stable. Additionally, AM Best has assigned a Long-Term IR of “bbb+” (Good) on $600 million 4.572% senior secured fixed rate, due 2029, of Equitable Holdings, Inc. The outlook assigned to this rating is stable. (Please see below for a detailed listing of the Long-Term IRs affirmations.)
By AM Best · Via Business Wire · March 4, 2026
BERLIN, March 04, 2026 (GLOBE NEWSWIRE) -- Sportstech Brands Holding GmbH today announced that the legal dispute between the Company and Interactive Strength Inc. (Nasdaq: TRNR) has been resolved amicably.
By Sportstech Brands Holding GmbH · Via GlobeNewswire · March 4, 2026